The fate of biocontrol agents under the European phytopharmaceutical regulation: how this regulation hinders the approva
- PDF / 395,615 Bytes
- 9 Pages / 595.276 x 790.866 pts Page_size
- 110 Downloads / 169 Views
TREND EDITORIAL
The fate of biocontrol agents under the European phytopharmaceutical regulation: how this regulation hinders the approval of botanicals as new active substances Marie-Cécile Vekemans 1 & Patrice A. Marchand 1 Received: 30 March 2020 / Accepted: 13 July 2020 # Springer-Verlag GmbH Germany, part of Springer Nature 2020
Abstract The use of biocontrol agents (BCAs) is growing across the world and in Europe in particular, where novel ways of farming are highly encouraged and implemented. However, although the social pressure is high to increase the number of BCAs in use within the EU, the European plant protection products (PPP) regulation (EC) N° 1107/2009 does not define clearly what BCAs are. Therefore, problems and drawbacks are observed throughout the whole authorisation process. Consequently, this situation impedes drastically the rapid implementation of botanical BCAs and their subsequent use in the field. Previous studies described in detail the fate of BCAs and the current administrative process that leads to their approval. Drawbacks are described for GMOs but surprisingly scarcely for pesticides. Therefore, the present study pinpoints the drawbacks of the approval process of botanical BCAs. To achieve this goal, a comparative study of 5 substances (4 of plant origin and 1 chemical) was performed. This study clearly reveals the present weaknesses and loopholes in the European PPP regulation process. The results of the present study may be useful to initiate and promote a major change in the evaluation and the regulation process of BCAs. This should allow designing a novel and innovative framework enabling the development of future plant protection products according to the sustainable use of pesticides, described in the corresponding (EC) Directive N° 128/2009 (SUD). This work targets farmers, policy makers, NGOs and scientists interested in issues related to this topic. Keywords Plant protection products . Biocontrol agents . Botanicals . Active substances . Regulatory improvements
Introduction The BCAs (biocontrol agents) market accounts for 3.6 billion euros worldwide and 900 million euros in Europe. In France, Highlights • There is a strong and increasing public demand for a general use of biocontrol agents. • Unfortunately, BCAs are not clearly defined within the European plant protection products (PPP) regulation. • Although BCAs are nevertheless considered as active substances, the approval pathway is strictly identical to that for synthetic chemicals and acts as a brake for mixtures of substances, especially botanicals. • Consequently, this drawback which occurs during the regulation process is seriously hindering the implementation and the field use of botanical BCAs. Responsible Editor: Giovanni Benelli * Patrice A. Marchand [email protected] 1
Institut de l’Agriculture et de l’Alimentation Biologiques (ITAB), 149 rue de BERCY F-75595, CEDEX 12 Paris, France
8% of the plant protection market deals with BCAs. This represents 170 million of euros (IBMA 2018). With a 20%
Data Loading...
